Global Information
회사소개 | 문의

미토콘드리아 열충격단백질 75kDa : 파이프라인 리뷰

Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Pipeline Review, H1 2018

리서치사 Global Markets Direct
발행일 2018년 05월 상품 코드 516033
페이지 정보 영문 23 Pages
가격
US $ 3,500 ₩ 4,001,900 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,000 ₩ 8,003,800 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,500 ₩ 12,005,700 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


미토콘드리아 열충격단백질 75kDa : 파이프라인 리뷰 Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Pipeline Review, H1 2018
발행일 : 2018년 05월 페이지 정보 : 영문 23 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

미토콘드리아 열충격단백질 75kDa(Heat Shock Protein 75 kDa Mitochondrial)를 표적으로 한 치료제 개발 파이프라인 현황과 최신 업데이트에 의한 각 개발 단계 비교 분석, 기업 및 연구기관이 개발중인 치료제, 치료제 평가, 후기 단계 및 중지된 프로젝트 관련 정보, 최신 뉴스와 발표 등의 정보를 정리하여 전해드립니다.

서론

  • 조사 범위

미토콘드리아 열충격단백질 75kDa : 개요

미토콘드리아 열충격단백질 75kDa : 치료제 개발

  • 개발중인 제품 : 개발 단계별
  • 개발중인 제품 : 치료 영역별
  • 개발중인 제품 : 증상별
  • 기업에서 개발중인 제품
  • 대학/연구기관에서 개발중인 제품

치료제 평가

  • 작용기전별
  • 분자 종류별

치료제 개발 참여 기업

  • Plex Pharmaceuticals Inc

약제 개요

부록

도표

LSH 17.10.16

List of Tables

  • Number of Products under Development by Stage of Development, H1 2018
  • Number of Products under Development by Therapy Areas, H1 2018
  • Number of Products under Development by Indication, H1 2018
  • Number of Products under Development by Companies, H1 2018
  • Products under Development by Companies, H1 2018
  • Number of Products under Investigation by Universities/Institutes, H1 2018
  • Products under Investigation by Universities/Institutes, H1 2018
  • Number of Products by Stage and Mechanism of Actions, H1 2018
  • Number of Products by Stage and Molecule Type, H1 2018
  • Pipeline by Plex Pharmaceuticals Inc, H1 2018

List of Figures

  • Number of Products under Development by Stage of Development, H1 2018
  • Number of Products under Development by Therapy Areas, H1 2018
  • Number of Products under Development by Top 10 Indications, H1 2018
  • Number of Products by Stage and Mechanism of Actions, H1 2018
  • Number of Products by Stage and Molecule Type, H1 2018

영문목차

Summary:

Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Heat shock protein 75 kDa mitochondrial is a protein that is encoded by the TRAP1 gene. It is a negative regulator of mitochondrial respiration able to modulate the balance between oxidative phosphorylation and aerobic glycolysis. This protein may function in regulating cellular stress responses.

Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) pipeline Target constitutes close to 5 molecules. Out of which approximately 3 molecules are developed by companies and remaining by the universities/institutes.

The molecules developed by companies in Preclinical and Discovery stages are 1 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 2 molecules, respectively. Report covers products from therapy areas Oncology and Genetic Disorders which include indications Glioblastoma Multiforme (GBM), Metastatic Brain Tumor and Neurofibromatoses Type II.

The latest report Heat Shock Protein 75 kDa Mitochondrial - Pipeline Review, H1 2018, outlays comprehensive information on the Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

It also reviews key players involved in Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) targeted therapeutics development with respective active and dormant or discontinued projects.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the global therapeutic landscape for Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1)
  • The report reviews Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) targeted therapeutics and enlists all their major and minor projects
  • The report assesses Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news and deals related to Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) targeted therapeutics

Reasons to buy:

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand the targeted therapy areas and indications for Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1)
  • Identify the use of drugs for target identification and drug repurposing
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) development landscape
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Overview
    • Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Therapeutics Development
    • Products under Development by Stage of Development
    • Products under Development by Therapy Area
    • Products under Development by Indication
    • Products under Development by Companies
    • Products under Development by Universities/Institutes
  • Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Therapeutics Assessment
    • Assessment by Mechanism of Action
    • Assessment by Molecule Type
  • Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Companies Involved in Therapeutics Development
    • Plex Pharmaceuticals Inc
  • Heat Shock Protein 75 kDa Mitochondrial (TNFR Associated Protein 1 or Tumor Necrosis Factor Type 1 Receptor Associated Protein or HSP 75 or TRAP1) - Drug Profiles
    • Panvotinib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule to Inhibit Hsp90 and TRAP1 for Glioblastoma Multiforme - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule to Inhibit Hsp90 and TRAP1 for Metastatic Brain Tumor - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule to Inhibit Hsp90-Alpha and TRAP1 for Neurofibromatosis Type 2 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • SMTIN-P01 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
  • Disclaimer
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research